Kukhona intuthuko yakamuva emkhakheni kagesi womlingo wokwelapha isimila sobuchopho.
I-Glioblastoma yisifo esibulalayo esibizwa nge- "terminator" ngoba lesi isimila sikhula ngokushesha okukhulu futhi singathinta noma ngubani wanoma yimuphi ubudala, ngesibikezelo esibi.
There is currently no cure for this tumor, and treatment is difficult because glioblastomas extend the antennae into the brain instead of forming a solid mass that a doctor can target and remove. So even if the surgical resection is clean, the average time to isisu recurrence is only 6.9 months, and the average survival time is only 14.6 months. During the treatment process, resistance to traditional treatment is prone to occur. What is more frightening is that this kind of Tumors have a curse that has a nearly 100% chance of recurrence.
Isandulela seDeveli Ozayo-Nyakazisa Umzimba Wakho Kancane
UScott Rider oneminyaka engama-61 uhlala eWilliamsport. Uthathe umhlalaphansi futhi uhlala nonkosikazi wakhe kanye nomzala wakhe, futhi unomzukulu othandekayo.
Ngelinye ilanga, wayegeza futhi wathola ukuthi umzimba wakhe wawubonakala ulokhu uncike waze wangena echibini kancane…
Wayengazi ukuthi kwenzekeni, kodwa ezinsukwini ezimbalwa ezalandela izinto zaba zimbi ngokwengeziwe. Waqala ukuzizwa ekhathele kakhulu, noma engenzanga lutho, futhi ekhathele kakhulu.
The family was a little worried whether it would be Alzheimer’s disease. He accompanied him to the hospital for a systematic examination. After the diagnosis, the whole family was shocked. Rider got one of the most deadly isimila sobuchopho, glioblastoma, but The predicted life can only be calculated in months, not years.
In April 2017, with the support of his family, he underwent surgery. The doctor said that at present the lesions were cut clean, but the fatality of this brain tumor is that it will definitely recur, but sooner or later the problem, so still You need to receive radiotherapy and chemotherapy as soon as possible to kill the remaining cancer cells in the body to the greatest extent and delay the recurrence as much as possible.
Inkambu kagesi “yomlingo” phakamisa umlingo wokuphindeka
Ngesikhathi samakhemikhali, udokotela owelapha uRider wathi i-FDA manje isivume indlela entsha yokwelapha, i-electric field therapy, eyaziwa nangokuthi i-Optune, enamaphakethe ama-electrode amane anamathele ekhanda eligundiwe lesiguli. Ikhiqiza amandla aphansi, amandla kagesi aphansi adluliswa yi-transducer array eya endaweni yesimila se-glioblastoma.
Electric fields can destroy rapidly dividing cancer cells, especially ama-gliomas, a type of tumor that divides rapidly.
Mr. Rider uses MRI to monitor brain tumors every other month. He said, “In the best case, it would shrink, but for me it didn’t grow anymore, it was very stable, which was very good.
Manje, uRider ukholelwa ukuthi inkambu kagesi "enamandla omlingo" iphakamisa isiqalekiso esiphindaphindayo kuye, futhi "ngumsizi" wakhe osindisa impilo.
Uyakhumbula ukuthi ngesikhathi ethola ukuthi une-glioblastoma, odokotela bathi unezinyanga eziyi-18 kuya kwengu-24 kuphela zokuphila. Kodwa-ke, manje sekuyinyanga yama-27 ngemuva kokuhlinzwa, futhi azikho izimpawu zokuphindeka, wathi uzohlala egqoka insimu kagesi ukuze iqhubeke nokusebenza.
Lapho uMnu. Rider engadingi msebenzi, wenza eminye yemidlalo ayithandayo, efana nokushushuluza neHockey. Lapho esekhaya, wayedlala nomzukulu wakhe othandekayo. Lona ngumlingo wokwelashwa kwenkambu kagesi. Ikuvumela ukuthi ulawule amangqamuzana omdlavuza emzimbeni wakho ngaphansi kwesimo sempilo ejwayelekile ngokuphelele. Amaseli nabantu ababazungezile banomphumela omubi.
UMnu Rider uthemba ukuthi impumelelo yakhe izonikeza ithemba nakwabanye. "Anginayo indlela yokunqoba isimila esibulalayo njengesicubu esibucayi sobuchopho, kodwa ngingaphila ngendlela enhle."
Ukwelashwa kwensimu kagesi-ubuchwepheshe obusha obuvunyelwe be-FDA bokwelashwa
I-Optune ivunyelwe yi-FDA futhi imbozwe yimishwalense eminingi.
Ukwelashwa kwensimu kagesi okwamanje kuvunyelwe yi-FDA yalokhu:
1. Treatment of adult patients with unresectable, locally advanced or metastatic i-mesothelioma (MPM), can be used with pemetrexed and platinum chemotherapy.
2. Adult patients (22 years or older) for histologically confirmed i-glioblastoma multiforme (GBM).
3. I-temozolomide ehlanganisiwe yokwelashwa kwe-glioblastoma esanda kutholakala ezigulini zabantu abadala.
4. Ngama-gliomas aphindaphindiwe ngemuva kokuthola i-chemotherapy, ukwelashwa kwenkambu kagesi kungamukelwa kukodwa.
The use of alternating low-intensity electric fields can destroy tumor cells and reduce damage to healthy tissues, which can effectively prevent side effects from affecting patients’ quality of life. Since 2000, the R & D team has been developing and expanding indications for electric field therapy. At present, researchers are conducting clinical trials on common solid tumors, including non-small cell lung cancer, non-small cell lung cancer brain metastasis, pancreatic cancer has launched phase III clinical trials, umdlavuza wesibeletho and mesothelioma have completed phase II clinical trials, will soon Entered Phase III trials, and liver cancer is undergoing Phase II trials. These cancers have achieved very exciting clinical data.
Insimu yokwelapha isimila i-Optune uhlelo olusha sha lokwelashwa kwesimila. Lokhu ukwelashwa okusebenzisa imvamisa ethile yensimu kagesi ukuphazamisa ukwahlukana kwamaseli, kuvimbela ukukhula kwesimila futhi kubangele ukuthi amangqamuzana omdlavuza athintwe insimu kagesi afe. Izifundo ze-in vitro ne-vivo zikuqinisekisile ukuthi izinkambu zikagesi zokwelashwa kwesimila zingabambezela futhi ziguqule ukukhula kwesimila ngokuvimbela i-mitosis yamangqamuzana wesimila.
Isazi esidumile sesimila sobuchopho uDkt Roger Stupp wake wathi:
“Eminyakeni engu-7 edlule, lapho ngiqala ukwelapha i-glioblastoma, iziguli eziningi zafa esikhathini esingaphansi konyaka, futhi cishe zazingekho izimo zokusinda isikhathi eside. Njengoba ukwelashwa kwenkundla yesimila kuhlanganiswe nokwelashwa kwe-temozolomide, zonke iziguli eziyi-5 Esinye sazo sasinda ngaphezu kweminyaka emi-XNUMX. “
Ngaphezu kwalokho, umphumela wokwelashwa kwensimu kagesi wesigaxa uhlobene kakhulu nokuhambisana. Lapho iziguli zigqoka ngaphezu kwamahora angama-22 ngosuku, izinga lokusinda leminyaka emihlanu lingakhuphukela ku-29.3%, okucishe kube izikhathi eziphindwe kathathu kunesilinganiso seminyaka emihlanu sokusinda kwe-temozolomide kuphela! Okubaluleke kakhulu, le ndlela yokwelashwa cishe ayinayo imiphumela emibi ebangelwa yi-chemoradiation. Okuvame kakhulu ukuqubuka endaweni yokuxhumana yephedi ye-electrode. Lokhu akukaze kwenzeke emlandweni wokwelashwa kwesimila ebuchosheni.
It is reported that Zaiding Pharmaceuticals is submitting an application for special approval of innovative medical devices to the State Drug Administration, and plans to submit an application for electric field therapy to be exempted from clinical trials. At the same time, it has completed a refinancing of US $ 200 million. Introduced Optune, a tumor electric field therapy, to start a new era of non-invasive tumor treatment! At present, you can go to Hong Kong through the Medical Department of Global Oncologist Network, and receive electric field treatment in Japan (400-666-7998)
I look forward to electric field therapy entering mainland China as soon as possible, and hope that this technology that brings huge survival benefits to cancer patients can enter medical insurance as soon as possible and bring the gospel to the majority of patients!
Izinkomba: https://www.pahomepage.com/news/using-electricity-to-treat-aggressive-brain-tumor/
